Meiling Zuo
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Mitochondrial Function and Pathology 3
- Metabolism, Diabetes, and Cancer 2
- Metabolomics and Mass Spectrometry Studies 2
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 3
- Co-authors
- Zhong‐Bao Yang (10 shared papers)Aiping Wang (5 shared papers)Guo‐Huang Hu (3 shared papers)Zhida Wu (2 shared papers)Li Chen (2 shared papers)He He (2 shared papers)Zheng Lou (2 shared papers)Chaojun Yan (2 shared papers)
- Journals
- BioMed Research International (2 papers)Biomedicine & Pharmacotherapy (2 papers)Cellular Physiology and Biochemistry (1 paper)Journal of Cellular Biochemistry (1 paper)Journal of the American Chemical Society (1 paper)
- Partner nations
- ChinaSaudi ArabiaHong Kong
In The Last Decade
Meiling Zuo
16 papers receiving 481 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 151
- Neurology 78
- Molecular Biology 284
- Immunology 74
- Geriatrics and Gerontology 11
Countries citing papers authored by Meiling Zuo
This map shows the geographic impact of Meiling Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiling Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiling Zuo more than expected).
Fields of papers citing papers by Meiling Zuo
This network shows the impact of papers produced by Meiling Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiling Zuo. The network helps show where Meiling Zuo may publish in the future.
Co-authors
The 25 scholars most cited alongside Meiling Zuo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 94 | |
| 2 | 2022 | 84 | |
| 3 | 2018 | 75 | |
| 4 | 2020 | 42 | |
| 5 | 2021 | 29 | |
| 6 | 2019 | 27 | |
| 7 | 2020 | 23 | |
| 8 | 2020 | 20 | |
| 9 | 2018 | 18 | |
| 10 | 2022 | 16 | |
| 11 | 2017 | 15 | |
| 12 | 2023 | 14 | |
| 13 | 2021 | 10 | |
| 14 | 2016 | 9 | |
| 15 | 2022 | 5 | |
| 16 | 2024 | 2 |
About Meiling Zuo
Meiling Zuo is a scholar working on Molecular Biology, Cancer Research, Neurology, Immunology and Surgery, having authored 16 papers that have together received 483 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Cancer-related molecular mechanisms research (3 papers), Mitochondrial Function and Pathology (3 papers), Metabolism, Diabetes, and Cancer (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers) and Adipose Tissue and Metabolism (2 papers). The work is most often cited by research in Cancer Research (151 citations), Neurology (78 citations), Molecular Biology (284 citations), Immunology (74 citations) and Geriatrics and Gerontology (11 citations). Meiling Zuo has collaborated with scholars based in China, Saudi Arabia and Hong Kong. Frequent co-authors include Zhong‐Bao Yang, Aiping Wang, Guo‐Huang Hu, Zhida Wu, Li Chen, He He, Zheng Lou, Chaojun Yan, Zhiyin Song and Mao Li. Their work appears in journals such as BioMed Research International, Biomedicine & Pharmacotherapy, Cellular Physiology and Biochemistry, Journal of Cellular Biochemistry and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.